

Feb 26 (Reuters) - British generic drugmaker Hikma Pharmaceuticals scrapped its medium-term targets as it forecast slower annual revenue growth and p...


(Alliance News) - Well-received corporate earnings supported European equities on Thursday, though shares in New York are set to open lower despite an...


(Alliance News) - Shares in Hikma Pharmaceuticals PLC on Thursday plummeted as it withdrew mid-term guidance and delivered a softer than hoped outlook...


(Alliance News) - European stocks were mixed in early dealings on Thursday, with markets awaiting a fresh set of catalysts after Nvidia beat on earnin...


(Sharecast News) - Shares in Hikma Pharmaceuticals tumbled on Thursday, after the generics drugmaker withdrew its medium-term guidance and adopted a c...


(Alliance News) - The FTSE 100 held steady on Tuesday, closing pretty much as it started for the second day in a row, despite concerns surrounding AI ...


(Alliance News) - Stocks in London slumped on Thursday, tracking US and European counterparts, as investors weighed rate calls in Europe and the UK an...


(Sharecast News) - Brookfield confirmed on Wednesday that it does not plan on making an offer for Hikma Pharmaceuticals.